PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 119 filers reported holding PROMETHEUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 10.24 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,309,304 | +3.5% | 12,200 | +6.1% | 0.00% | 0.0% |
| Q4 2022 | $1,265,000 | +86.3% | 11,500 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $679,000 | -60.7% | 11,500 | -81.2% | 0.00% | -50.0% |
| Q2 2022 | $1,726,000 | +38.0% | 61,133 | +84.5% | 0.00% | +100.0% |
| Q1 2022 | $1,251,000 | +185.6% | 33,135 | +199.3% | 0.00% | – |
| Q4 2021 | $438,000 | – | 11,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 1,848,024 | $198,329,936 | 93.93% |
| CHI Advisors LLC | 934,135 | $100,251,367 | 26.61% |
| Cormorant Asset Management, LP | 1,655,000 | $177,615 | 11.70% |
| Boxer Capital, LLC | 1,897,500 | $203,640 | 10.00% |
| RTW INVESTMENTS, LP | 3,272,104 | $351,162,201 | 7.31% |
| Decheng Capital Management III (Cayman), LLC | 150,000 | $16,098,000 | 6.50% |
| Waypoint Capital Advisors, LLC | 154,466 | $16,577,292 | 5.40% |
| Affinity Asset Advisors, LLC | 150,000 | $16,098,000 | 5.31% |
| Perceptive Advisors | 1,272,694 | $136,585,520 | 4.03% |
| Ikarian Capital, LLC | 125,926 | $13,514,378 | 3.07% |